| N04BD01 |
Selegiline |
N04BD01 Selegiline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N04BD01 |
Selegiline |
JAMAX |
Tablet |
5 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
5 |
mg |
- |
11.15 |
0.322 |
9.66 |
75% |
7.25 |
|
G20 |
Прот. № 117/21.05.2015; НСР-18192/19.03.2019 |
02.05.2019 |
08.09.2012 |
16.11.2013 |
Активен |
264 |
| N04BD01 |
Selegiline |
JUMEX |
Tablet |
5 |
mg |
50 |
Санофи България ЕООД, България |
5 |
mg |
- |
17 |
0.322 |
16.1 |
75% |
12.08 |
|
G20 |
НСР-71/07.06.2013; Прот. № 117/21.05.2015 |
02.06.2015 |
08.09.2012 |
|
Активен |
1904 |
| N04BD01 |
Selegiline |
SELEGOS |
Tablet |
5 |
mg |
50 |
Medochemie Ltd., Кипър |
5 |
mg |
- |
16.02 |
0.3204 |
16.02 |
75% |
12.02 |
|
G20 |
№98/23.08.2010; НСР-3467/16.05.2014 |
16.06.2014 |
08.09.2012 |
|
Заличен |
841 |
| N04BD01 |
Selegiline |
SELEGOS |
Tablet |
5 |
mg |
30 |
Medochemie Ltd., Кипър |
5 |
mg |
- |
9.66 |
0.322 |
9.66 |
75% |
7.25 |
|
G20 |
№98/23.08.2010; Прот. № 117/21.05.2015 |
02.06.2015 |
08.09.2012 |
|
Активен |
840 |
| N04BD02 |
Rasagiline |
N04BD02 Rasagiline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N04BD02 |
Rasagiline |
AZILECT |
Tablet |
1 |
mg |
28 |
Teva B.V., Нидерландия |
1 |
mg |
- |
205.73 |
5.87767 |
164.57 |
25% |
41.14 |
|
G20 |
№ 51/ 18.02.2010; КЦРР-1788/10.12.2012 г; НСР-850/07.08.2013; НСР-9157/27.04.2016 |
02.06.2016 |
08.09.2012 |
|
Заличен |
2059 |
| N04BD02 |
Rasagiline |
Rasagiline Accord |
Tablet |
1 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
1 |
mg |
- |
52.86 |
1.762 |
52.86 |
25% |
13.21 |
|
G20 |
НСР-16840/20.09.2018 |
02.11.2018 |
|
|
Активен |
16289 |
| N04BD02 |
Rasagiline |
Sagilia |
Tablet |
1 |
mg |
60 |
Medochemie Ltd., Кипър |
1 |
mg |
- |
394.42 |
1.762 |
105.72 |
25% |
26.43 |
|
G20 |
НСР-11881/06.03.2017; НСР-18805/30.05.2019 |
02.07.2019 |
|
|
Активен |
15622 |
| N04BD02 |
Rasagiline |
Sagilia |
Tablet |
1 |
mg |
30 |
Medochemie Ltd., Кипър |
1 |
mg |
- |
111.25 |
3.70833 |
111.25 |
25% |
27.81 |
|
G20 |
НСР-8539/24.03.2016 и НСР-8660/01.04.2016; КП-20/11.04.2017 и НСР-11215/15.12.2016; НСР-14042/02.10.2017 |
02.11.2017 |
|
|
Заличен |
4214 |
| N04BX02 |
Entacapone |
N04BX02 Entacapone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N04BX02 |
Entacapone |
COMTAN |
Film coated tablet |
200 |
mg |
30 |
Novartis Europharm Limited, Обединено Кралство |
1000 |
mg |
- |
50.77 |
8.46167 |
50.77 |
25% |
12.69 |
|
G20 |
№ 51/ 18.02.2010; КЦРР-995/23.07.2012 г; НСР-913/12.08.2013;НСР-1282/25.09.2013 |
16.10.2013 |
08.09.2012 |
|
Заличен |
2057 |
| N05AB02 |
Fluphenazine |
N05AB02 Fluphenazine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N05AB02 |
Fluphenazine |
MODITEN DEPO solution for injection 25 mg/ml x 5 |
Solution for injection |
25 |
mg/ml |
5 |
KRKA, d.d., Словения |
1 |
mg |
16.61 |
- |
0.13288 |
16.61 |
100% |
16.61 |
|
F20.0,F20.1,F20.5,F20.6,F30.0,F30.1,F31.1,F31.2,F31.5,F31.6,F33.3 |
НСР-7971/08.02.2016. |
02.03.2016 |
08.09.2012 |
|
Заличен |
440 |
| N05AC02 |
Thioridazine |
N05AC02 Thioridazine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N05AC02 |
Thioridazine |
THIORIDAZIN ACTAVIS |
Film coated tablet |
25 |
mg |
50 |
Актавис EАД, България |
300 |
mg |
- |
5.89 |
1.4136 |
5.89 |
25% |
1.47 |
|
F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-1094/02.09.2013 |
02.10.2013 |
08.09.2012 |
|
Заличен |
486 |
| N05AC02 |
Thioridazine |
THIORIDAZIN ACTAVIS |
Film coated tablet |
5 |
mg |
25 |
Актавис EАД, България |
300 |
mg |
- |
1.66 |
1.4136 |
0.59 |
25% |
0.15 |
|
F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-1096/02.09.2013 |
02.10.2013 |
08.09.2012 |
|
Заличен |
560 |
| N05AC02 |
Thioridazine |
THIORIDAZIN ACTAVIS |
Film coated tablet |
10 |
mg |
25 |
Актавис EАД, България |
300 |
mg |
- |
2.75 |
1.4136 |
1.18 |
25% |
0.3 |
|
F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-1095/02.09.2013 |
02.10.2013 |
08.09.2012 |
|
Заличен |
487 |
| N05AD01 |
Haloperidol |
N05AD01 Haloperidol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N05AD01 |
Haloperidol |
HALOPERIDOL-RICHTER |
Tablet |
1.5 |
mg |
50 |
Gedeon Richter Plc., Унгария |
8 |
mg |
2.99 |
- |
0.31876 |
2.99 |
100% |
2.99 |
|
F20.0,F20.1,F20.5,F20.6,F30.0,F30.1,F31.0,F31.1,F31.2,F31.6 |
№ 202/ 19.10.2011.; НСР-6778/23.07.2015 |
16.08.2015 |
08.09.2012 |
|
Активен |
1045 |
| N05AE03 |
Sertindole |
N05AE03 Sertindole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N05AE03 |
Sertindole |
SERDOLECT |
Film coated tablet |
4 |
mg |
30 |
Lundbeck Export A/S, Дания |
16 |
mg |
43.1 |
- |
5.74667 |
43.1 |
100% |
43.1 |
За експертиза по чл. 78 т.2 от ЗЗО |
F20.0,F20.1,F20.5,F20.6 |
КЦРР-2548/14.03.2013 г.; НСР-1728/21.11.2013; НСР-5580/05.02.2015; НСР-7307/29.10.2015; НСР-9620/23.06.2016 г.; НСР-12215/03.04.2017; НСР-15671/17.05.2018 |
02.06.2018 |
08.09.2012 |
|
Активен |
3572 |
| N05AE03 |
Sertindole |
SERDOLECT |
Film coated tablet |
16 mg |
|
28 |
Lundbeck Export A/S, Дания |
16 |
mg |
174.29 |
- |
5.74667 |
160.91 |
100% |
160.91 |
За експертиза по чл. 78 т.2 от ЗЗО |
F20.0,F20.1,F20.5,F20.6 |
КЦРР-2544/14.03.2013 г.; НСР-1729/21.11.2013; НСР-4336/05.08.2014; НСР-5981/01.04.2015.; НСР-7591/26.11.2015.; НСР-12499/28.04.2017 г.; НСР-14902/25.01.2018; НСР-18998/13.06.2019 |
02.07.2019 |
08.09.2012 |
|
Активен |
3788 |
| N05AE03 |
Sertindole |
SERDOLECT |
Film coated tablet |
12 |
mg |
28 |
Lundbeck Export A/S, Дания |
16 |
mg |
131.98 |
- |
5.74667 |
120.68 |
100% |
120.68 |
За експертиза по чл. 78 т.2 от ЗЗО |
F20.0,F20.1,F20.5,F20.6 |
КЦРР-2545/14.03.2013 г.; НСР-3331/24.04.2014; НСР-5395/07.01.2015; НСР-7077/09.09.2015; НСР-9119/27.04.2016; НСР-11560/26.01.2017 г.; НСР-14274/26.10.2017 |
02.06.2018 |
08.09.2012 |
|
Активен |
3487 |
| N05AE04 |
Ziprasidone |
N05AE04 Ziprasidone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|